Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,830 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development. Yawn BP, et al. Among authors: black p. Proc Am Thorac Soc. 2012 Dec;9(5):219-24. doi: 10.1513/pats.201208-054ST. Proc Am Thorac Soc. 2012. PMID: 23256162 Review.
Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Burgers JS, Anzueto A, Black PN, Cruz AA, Fervers B, Graham ID, Metersky M, Woodhead M, Yawn BP; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development. Burgers JS, et al. Among authors: black pn. Proc Am Thorac Soc. 2012 Dec;9(5):304-10. doi: 10.1513/pats.201208-067ST. Proc Am Thorac Soc. 2012. PMID: 23256175 Review.
25 years International Bladder Cancer Network (IBCN): The past, the present, and the future.
Dyrskjøt L, Vlahou A, Black PC, Droller M, Grossmann HB, Goebell PJ, Kamat AM, Nawroth R, Seiler R, Todenhöfer T, Williams SB, Schmitz-Dräger BJ. Dyrskjøt L, et al. Among authors: black pc. Urol Oncol. 2022 Nov 24:S1078-1439(22)00430-6. doi: 10.1016/j.urolonc.2022.10.031. Online ahead of print. Urol Oncol. 2022. PMID: 36437158 Review.
IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer.
Christensen E, Wyatt AW, Galsky MD, Grivas P, Seiler R, Nawroth R, Goebell PJ, Schmitz-Drager BJ, Williams SB, Black PC, Kamat AM, Todenhöfer T, Dyrskjøt L. Christensen E, et al. Among authors: black pc. Urol Oncol. 2022 Nov 24:S1078-1439(22)00442-2. doi: 10.1016/j.urolonc.2022.11.008. Online ahead of print. Urol Oncol. 2022. PMID: 36437155 Review. No abstract available.
Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC. Bénard F, et al. Among authors: black p. Lancet Oncol. 2022 Nov 4:S1470-2045(22)00642-8. doi: 10.1016/S1470-2045(22)00642-8. Online ahead of print. Lancet Oncol. 2022. PMID: 36343655
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.
Reike MJ, Ingersoll MA, Müller DC, Zuiverloon TCM, Strandgaard T, Kamat AM, Williams SB, Seiler R, Todenhöfer T, Dyrskjøt L, Nawroth R, Goebell P, Schmitz-Dräger B, Sfakianos JP, Meeks J, Horowitz A, Black PC. Reike MJ, et al. Among authors: black pc. Urol Oncol. 2022 Oct 17:S1078-1439(22)00340-4. doi: 10.1016/j.urolonc.2022.09.012. Online ahead of print. Urol Oncol. 2022. PMID: 36266219 Review.
Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index Threshold.
McLoughlin LC, Kassouf W, Breau RH, Fairey A, Agnihotram V R, Salimi A, Hyndman E, Drachenberg DE, Izawa J, Shayegan B, Lattouf JB, Lodde M, Rendon R, Siemens DR, Jeldres C, Black PC, Kulkarni GS. McLoughlin LC, et al. Among authors: black pc. J Urol. 2022 Oct 11:101097JU0000000000002988. doi: 10.1097/JU.0000000000002988. Online ahead of print. J Urol. 2022. PMID: 36250946
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
Einerhand SMH, Black AJ, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Zargar-Shoshtari K, Spiess PE, van Rhijn BWG, Black PC, Mertens LS. Einerhand SMH, et al. Among authors: black pc. World J Urol. 2022 Nov;40(11):2707-2715. doi: 10.1007/s00345-022-04160-7. Epub 2022 Sep 28. World J Urol. 2022. PMID: 36169695
1,830 results